Thirty Years of Hydroxyurea for Sickle Cell Anemia — Scientific Progress, Global Health Gaps
Enrico Costa(Brigham and Women's Hospital), Lucio Luzzatto(University of Florence), Léon Tshilolo(National Institute of Biomedical Research), Russell E. Ware(Cincinnati Children's Hospital Medical Center)
Cited by 3
Related Papers
Management of Sickle Cell Disease
|JAMA|2014|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Natural History of Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|1995|900
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
|Survey of Anesthesiology|2015|270